Medical Journals

The Organotellurium Compound Ammonium Trichloro(Dioxoethylene-0,0') Tellurate Enhances Neuronal Survival and Improves Functional Outcome in an Ischemic Stroke Model in Mice.

Authors:
  • Okun Eitan
  • Arumugam Thiruma V
  • Tang Sung-Chun
  • Gleichmann Marc
  • Albeck Michael
  • Sredni Benjamin
  • Mattson Mark P

From: CAIR Institute, Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel.

Journal of neurochemistry

  • Publish Date: Aug 2007
  • ISSN: 0022-3042
  • Volume: 102
  • Issue: 4
  • Pages: 1232-41
  • Medium: Print
  • Language: English
  • Citation (JAMA): Okun Eitan, Arumugam Thiruma V, Tang Sung-Chun, et al. The Organotellurium Compound Ammonium Trichloro(Dioxoethylene-0,0') Tellurate Enhances Neuronal Survival and Improves Functional Outcome in an Ischemic Stroke Model in Mice.. J. Neurochem. Aug 2007;102:1232-41

Abstract

Ammonium trichloro(dioxoethylene-0,0’) tellurate (AS101) is a non-toxic organotellurium compound with pleiotropic activities. It was recently shown to induce production of the neurotrophic factor glial cell line-derived neurotrophic factor and to rescue neuronal-like PC-12 cells from neurotrophic factor deprivation-induced apoptosis. In this study, we show that AS101 improves functional outcome and reduces brain damage in a mouse model of focal ischemic stroke. Both pre-stroke and post-stroke intraperitoneal treatments with AS101 reduced infarct size and edema and improved the neurological function of the animals. AS101 treatments reduced both apoptotic and inflammatory caspase activities, and also inhibited protein tyrosine nitration suggesting that AS101 suppresses oxidative stress. Studies of cultured neurons showed that AS101 confers protection against apoptosis induced by either glucose deprivation or the lipid peroxidation product 4-hydroxynonenal. Moreover, AS101 treatment reduced glutamate-induced intracellular calcium elevation, a major contributor to neuronal death in stroke. As AS101 has an excellent safety profile in humans, our pre-clinical data suggest a potential therapeutic benefit of AS101 in patients suffering from stroke and other neurodegenerative conditions.

Mesh Headings (Keywords): Analysis of Variance, Animals, Animals, Newborn, Anoxia, Calcium, Caspases, Cell Survival, Cells, Cultured, Disease Models, Animal, Dose-Response Relationship, Drug, Ethylenes, Glucose, Infarction, Middle Cerebral Artery, Male, Mice, Mice, Inbred C57BL, Neurons, Neuroprotective Agents, Rats, Time Factors


Check for Full Text / PubMed Unique Identifier (PMID): 17542809


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.